SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves selloff is being tied to concerns over its debt-heavy AI infrastructure expansion, with bond yields near distressed levels and a bearish analyst warning that shareholders could be wiped out if AI spending weakens; Gartners forecast that many independent neoclouds may not survive also adds to the concern. Traders are split between fears of financing strain and bankruptcy versus confidence in the companys backlog and continued AI demand, with some buying the dip.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

The FDA expanded Anktivas approval to cover BCG-unresponsive, high-grade papillary-only bladder cancer, broadening its potential market. Traders largely view the decision as a significant revenue and pipeline positive, but many are frustrated by the stocks muted response and debate whether the news was already priced in; claims of short-selling pressure and a possible squeeze remain speculation.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is drawing attention after a sharp selloff amid a broader tech and AI-stock decline, with traders pointing to hotter-than-expected inflation and renewed concerns about data-center spending, debt, cash flow and AI-related financing risks. Bulls call the drop an overreaction and are buying or averaging down, while bears expect further pressure until funding and execution concerns ease.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Regna AI venture with Palantir is driving attention, with traders focused on its potential to combine Palantirs AI platform with Ondas autonomous defense systems. Optimists see a new growth opportunity, while skeptics point to the stocks continued weakness, dilution concerns and unproven profitability.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SOFI is drawing attention after a steep selloff and fresh 52-week lows, which traders largely attribute to hotter inflation, rising Treasury yields and renewed Fed rate-hike fears weighing on rate-sensitive financial stocks. The debate is between investors buying the drop as a macro-driven overreaction and bears expecting more downside; some holders also fault dilution and management as they look ahead to earnings.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A hotter-than-expected CPI reading intensified inflation and rate-hike concerns, with traders citing rising yields and pressure on tech and AI-related shares as drivers of QQQs selloff. The community is split between expecting a relief bounce from support and anticipating further losses, with some also pointing to fears about stretched AI valuations and debt.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

RKLB is under pressure amid a broader pullback in high-growth and space stocks, with traders also pointing to uncertainty around Neutrons progress and launch timing as an added overhang. Some investors view the selloff as a buying opportunity based on Rocket Labs longer-term business and contracts, while others remain concerned about delays, valuation, and continued downside.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Cipher Digitals convertible-note offering has fueled a sharp selloff, with traders worried about dilution and hedging-related selling; some bullish investors argue the financing provides low-cost capital for its AI data-center expansion. Broader weakness in high-growth data-center and crypto-mining stocks, alongside inflation and rate concerns, adds to the pressure.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

WULFs sharp decline is being linked to broad selling in crypto-mining and AI data-center stocks after a hotter inflation reading renewed rate and yield concerns and weighed on Bitcoin. Traders debate whether the pressure is mainly macro and sector-wide or reflects WULFs financing, dilution, and execution risks, while bulls point to its AI/HPC hosting contracts as a longer-term positive.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

A sharp semiconductor selloff, magnified by SOXLs 3 leverage, is being linked to hotter inflation data, fears of Chinese chip competition, and concerns about AI valuations. Traders are split between calling the decline an overreaction and seeking an oversold bounce, and warning that selling pressure could continue.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Evotec Sees 9-Month Results Above Market; Reiterates FY26 Outlook

(RTTNews) - Evotec SE (EVTG.DE, EVTCY.PK, EVO), a German healthcare company, announced preliminary results for the first nine months of 2026 that came in above market expectations, while reaffirming its fiscal 2026 guidance...

Evotec Announces Chief Scientific Officer Transition

Evotec Announces Chief Scientific Officer Transition Evotec Announces Chief Scientific Officer TransitionPR NewswireHAMBURG, Germany, Sept. 29, 2026 Dr. Cord Dohrmann to step down as of September 30, 2026Search ongoing for a successorHAMBURG, Germany, Sept. 29, 2026 /PRNewswire/ -- Evotec SE...

12 Health Care Stocks Moving In Monday's After-Market Session

Gainers

Milestone Scientific (AMEX:MLSS) stock moved upwards by 11.8% to $0.44 during Monday's after-market session. The company's market cap stands at $36.9 million.
Evotec (NASDAQ:EVO) stock rose 8.44% toread more...

Just - Evotec Biologics Advances U.S. Department of War Antibodies Against Orthopoxvirus into Phase 1 Clinical Studies

Just - Evotec Biologics Advances U.S. Department of War Antibodies Against Orthopoxvirus into Phase 1 Clinical Studies Just - Evotec Biologics Advances U.S. Department of War Antibodies Against Orthopoxvirus into Phase 1 Clinical Studies PR Newswire SEATTLE and HAMBURG, Germany, Sept. 9, 2026...

Evotec and Plectonic Enter Research Collaboration to Explore New Generation of T-Cell-Engaging Approaches for Solid Tumors

Evotec and Plectonic Enter Research Collaboration to Explore New Generation of T-Cell-Engaging Approaches for Solid Tumors Evotec and Plectonic Enter Research Collaboration to Explore New Generation of T-Cell-Engaging Approaches for Solid Tumors PR Newswire HAMBURG, Germany and HALLBERGMOOS...

Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases

Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases PR Newswire HAMBURG, Germany, Aug. 6, 2026 Collaboration combines Odyssey's disease...

Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that it has selected Evotec (NASDAQ: EVO; Frankfurt Prime Standard: EVT), a global life science company specializing in drug...

Evotec Selects Navan to Unify Global Travel, Payments, and Expense Management

Navan (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced that Evotec (NASDAQ: EVO; Frankfurt Prime Standard: EVT), the global drug discovery and development company, has selected Navan to manage its complete corporate Travel and Expense (T&E) program in its...

Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook

Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook PR Newswire HAMBURG, Germany, July 13, 2026 Disclosure of an inside...

Just - Evotec Biologics Launches J.TRAIN to Deliver Turnkey Continuous Manufacturing for Biologics

Just - Evotec Biologics Launches J.TRAIN to Deliver Turnkey Continuous Manufacturing for Biologics Just - Evotec Biologics Launches J.TRAIN to Deliver Turnkey Continuous Manufacturing for Biologics PR Newswire SEATTLE and HAMBURG, Germany, June 30, 2026 Expands Just Evotec Biologics...

Evotec SE is a life science company, which engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the Shared R&D and Just–Evotec Biologics segments. The Shared R&D segment includes drug discovery and development services and solutions. The Just–Evotec Biologics segment provides services related to designing, discovering, developing, and manufacturing of modern biotherapeutics. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, Charles Weissmann, and Nobel Laureate on December 8, 1993 and is headquartered in Hamburg, Germany.

Evotec SE - ADR

Bullish Sentiment

Hotter than expected

As expected

Cooler than expected

The September Producer Price Index report lands Thursday, October 15 at 8:30 AM ET, one day after CPI, with August’s reading at 5.4% year over year, as investors look for clues on inflation before the Fed’s October 27-28 meeting. How will the September PPI print compare to consensus expectations? Vote and explain your reasoning in the comments.

How will the September PPI print compare to consensus expectations?

Feed

News

Sentiment

Fundamentals

Info

EVO Eaton Vance Ohio Municipal Income Trust

Fundamentals

Latest EVO News